Rank 83 • MedTech & Devices
SetPoint Medical
Develops an implantable bioelectronic medicine platform designed to treat chronic inflammatory diseases via vagus nerve stimulation.
Visit website- Signal Score
- 84
- Total raised
- $180M
- Stage
- Series D+
- Founded
- 2006
- Headquarters
- Valencia, United States
- Region
- North America
Their signal
SetPoint leads the therapeutic field of bioelectronic medicine. Its micro-regimen vagus nerve stimulator aims to replace biological drugs for rheumatoid arthritis, backed by high-quality clinical trials and strong venture backing.
Signal Score 84editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.